Literature DB >> 16824250

Prevalence of hepatitis C in a German prison for young men in relation to country of birth.

M F Meyer1, H Wedemeyer, M Monazahian, J Dreesman, M P Manns, M Lehmann.   

Abstract

A high prevalence of hepatitis C (HCV) virus infection of up to 80% has been reported for injecting drug users (IDUs) in prison communities. However, there are only very limited data available on the prevalence and course of HCV in young offenders. We performed a study on hepatitis C markers in the largest German Young Offenders' Institution (YOI), a prison for men (aged 16-24 years). In 2002, all 1176 incoming offenders were asked to participate in the study of whom >95% agreed. Ninety-seven inmates (8.6%) tested positive for anti-HCV or HCV RNA, 79% of whom were viraemic. None of the patients had evidence of cirrhosis at presentation. Interestingly, six individuals (6%) tested positive for HCV RNA in the absence of anti-HCV antibodies, four of whom cleared HCV spontaneously during follow-up without either clinical signs of acute hepatitis or developing HCV antibodies. Hepatitis C markers were significantly more prevalent among immigrants from the former Soviet Union (NIS) than among German inmates (31% vs. 6% respectively, P<0.0001). HIV co-infection was found in five individuals, all of whom were German. In contrast, hepatitis B surface antigen (HBsAg) was detected in five NIS immigrants, one Lebanese and one German inmate. HCV genotypes 2 and 3 were more prevalent in immigrants than in German inmates, while biochemical parameters did not differ significantly between the two groups. In conclusion, the prevalence of hepatitis C was relatively low among inmates of German YOIs although there were significant differences in relation to the country of birth. Our data highlight the need for educational programmes for young offenders in order to prevent the further spread of HCV.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16824250      PMCID: PMC2870573          DOI: 10.1017/S0950268806006820

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  24 in total

1.  Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey.

Authors:  A R Weild; O N Gill; D Bennett; S J Livingstone; J V Parry; L Curran
Journal:  Commun Dis Public Health       Date:  2000-06

2.  Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey.

Authors:  J Long; S Allwright; J Barry; S R Reynolds; L Thornton; F Bradley; J V Parry
Journal:  BMJ       Date:  2001-11-24

Review 3.  Side effects of therapy of hepatitis C and their management.

Authors:  Michael W Fried
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Cigarette smoking and hepatic lesions in patients with chronic hepatitis C.

Authors:  F Pessione; M J Ramond; C Njapoum; V Duchatelle; C Degott; S Erlinger; B Rueff; D C Valla; F Degos
Journal:  Hepatology       Date:  2001-07       Impact factor: 17.425

Review 5.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

Review 6.  Prevention of spread of hepatitis C.

Authors:  Miriam J Alter
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

7.  Impact of smoking on histological liver lesions in chronic hepatitis C.

Authors:  C Hézode; I Lonjon; F Roudot-Thoraval; J-P Mavier; J-M Pawlotsky; E S Zafrani; D Dhumeaux
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

8.  Prevalence and incidence of bloodborne viral infections among Danish prisoners.

Authors:  P B Christensen; H B Krarup; H G Niesters; H Norder; J Georgsen
Journal:  Eur J Epidemiol       Date:  2000       Impact factor: 8.082

9.  Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study.

Authors:  M Wiese; F Berr; M Lafrenz; H Porst; U Oesen
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

10.  Prevalence of hepatitis C virus infection and risk factors in an incarcerated juvenile population: a pilot study.

Authors:  Karen F Murray; Laura P Richardson; Chihiro Morishima; James W M Owens; David R Gretch
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

View more
  17 in total

1.  Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary.

Authors:  Bálint Tresó; Erzsébet Barcsay; Anna Tarján; Gergely Horváth; Agnes Dencs; Andrea Hettmann; Mária Magdolna Csépai; Zoltán Gyori; Erzsébet Rusvai; Mária Takács
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

2.  Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection.

Authors:  Sayed F Abdelwahab; Zainab Zakaria; Maha Sobhy; Eman Rewisha; Mohamed A Mahmoud; Mahmoud A Amer; Mariarosaria Del Sorbo; Stefania Capone; Alfredo Nicosia; Antonella Folgori; Mohamed Hashem; Samer S El-Kamary
Journal:  Clin Vaccine Immunol       Date:  2012-03-21

3.  Prevalence, genotypes and factors associated with HCV infection among prisoners in Northeastern Brazil.

Authors:  Bruno Fernandes de Oliveira Santos; Nathalie Oliveira de Santana; Alex Vianey Callado Franca
Journal:  World J Gastroenterol       Date:  2011-07-07       Impact factor: 5.742

Review 4.  Hepatitis C virus infection and prisoners: Epidemiology, outcome and treatment.

Authors:  Rosa Zampino; Nicola Coppola; Caterina Sagnelli; Giovanni Di Caprio; Evangelista Sagnelli
Journal:  World J Hepatol       Date:  2015-09-28

5.  Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012.

Authors:  Madeline K Mahowald; Sarah Larney; Nickolas D Zaller; Nicholas Scharff; Lynn E Taylor; Curt G Beckwith; Amanda Noska; Josiah D Rich; Timothy P Flanigan
Journal:  J Correct Health Care       Date:  2016-01

6.  Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran.

Authors:  Zary Nokhodian; Behrooz Ataei; Nazila Kassaian; Majid Yaran; Razieh Hassannejad; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03

Review 7.  Seronegative hepatitis C virus infection.

Authors:  Justyna Kaźmierczak; Agnieszka Pawełczyk; Kamila Caraballo Cortes; Marek Radkowski
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-11-09       Impact factor: 4.291

Review 8.  Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV+ MSM): a systematic review and meta-analysis.

Authors:  Daniel J Smith; Ashly E Jordan; Mayu Frank; Holly Hagan
Journal:  BMC Infect Dis       Date:  2016-09-05       Impact factor: 3.090

9.  Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response.

Authors:  Manuela F Meyer; Marc Lehmann; Markus Cornberg; Johannes Wiegand; Michael P Manns; Christoph Klade; Heiner Wedemeyer
Journal:  Virol J       Date:  2007-06-11       Impact factor: 4.099

10.  Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz.

Authors:  Malgorzata Tyczyno; Waldemar Halota; Wojciech Nowak; Małgorzata Pawlowska
Journal:  Hepat Mon       Date:  2014-05-03       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.